1,9-dimethylmethylene blue has been researched along with dipyridamole in 1 studies
Studies (1,9-dimethylmethylene blue) | Trials (1,9-dimethylmethylene blue) | Recent Studies (post-2010) (1,9-dimethylmethylene blue) | Studies (dipyridamole) | Trials (dipyridamole) | Recent Studies (post-2010) (dipyridamole) |
---|---|---|---|---|---|
81 | 1 | 6 | 7,826 | 881 | 632 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Besselink, GA; Blokker, DE; Brand, A; De Korte, D; Korsten, HG; Lagerberg, JW; Van Engelenburg, FA; Verhoeven, AJ | 1 |
1 other study(ies) available for 1,9-dimethylmethylene blue and dipyridamole
Article | Year |
---|---|
The band III ligand dipyridamole protects human RBCs during photodynamic treatment while extracellular virus inactivation is not affected.
Topics: Anion Exchange Protein 1, Erythrocyte; Diarrhea Viruses, Bovine Viral; Dipyridamole; Encephalomyocarditis virus; Erythrocyte Membrane; Erythrocytes; Free Radical Scavengers; Hemolysis; Herpesvirus 1, Suid; HIV-1; Humans; Ligands; Methylene Blue; Oxidative Stress; Parvovirus, Canine; Photochemistry; Photochemotherapy; Radiation-Protective Agents; Radiation-Sensitizing Agents; Vesicular stomatitis Indiana virus; Viruses | 2002 |